Towards elimination: measles susceptibility in Australia and 17 European countries. - Wikidata - wikimedia - TriplyDB

Towards elimination: measles susceptibility in Australia and 17 European countries.

Towards elimination: measles susceptibility in Australia and 17 European countries.

http://www.wikidata.org/entity/Q37108714

about

Seroepidemiology: an underused tool for designing and monitoring vaccination programmes in low- and middle-income countries Influenza serological studies to inform public health action: best practices to optimise timing, quality and reporting.Quantifying child mortality reductions related to measles vaccination.Estimating vaccination coverage for the trivalent measles-mumps-rubella vaccine from trivariate serological data.Seroprevalence of measles, mumps and rubella among young adults, after 20 years of universal 2-dose MMR vaccination in Israel.Obstacles in measles elimination: an in-depth description of a measles outbreak in Ghent, Belgium, spring 2011 Comparison of rubella seroepidemiology in 17 countries: progress towards international disease control targets.Seroprevalence of Antibodies against Measles, Rubella and Varicella among Asylum Seekers Arriving in Lower Saxony, Germany, November 2014-October 2015.Underreporting of viral encephalitis and viral meningitis, Ireland, 2005-2008.Seroprevalences of Specific IgG Antibodies to Measles, Mumps, and Rubella in Korean Infants.Assessing vaccination coverage in the European Union: is it still a challenge?Measles elimination: progress, challenges and implications for rubella control.Systematic Review of Measles and Rubella Serology Studies.Synthesis of Evidence to Characterize National Measles and Rubella Exposure and Immunization Histories.The measles outbreak in Bulgaria, 2009-2011: An epidemiological assessment and lessons learnt.Estimating seroprevalence of vaccine-preventable infections: is it worth standardizing the serological outcomes to adjust for different assays and laboratories?Serology indicates cytomegalovirus infection is associated with varicella-zoster virus reactivation.Measles outbreak in Bulgaria: poor maternal educational attainment as a risk factor for medical complications.Prevalence of antibodies against measles, mumps and rubella in the childhood population in Singapore, 2008-2010.Letter to the editor: The measles outbreak in Bulgaria, 2009-2011: an epidemiological assessment and lessons learnt--but not completely yet.Europe Should Consider Mandatory Measles Immunization for School Entry.Rubella vaccination in India: identifying broad consequences of vaccine introduction and key knowledge gaps.Seroepidemiology of mumps in Europe (1996-2008): why do outbreaks occur in highly vaccinated populations?Assessment of RNA amplification by multiplex RT-PCR and IgM detection by indirect and capture ELISAs for the diagnosis of measles and rubella.

P2860

Q28078813-019F0A6F-7040-497C-B371-0A0E77DE03BF Q30416214-4929399E-F27F-45DF-815F-87E5F9C36C24 Q33747882-075268CA-7680-4756-9F39-D25B4794B4FD Q34169393-638824E9-A473-4BFF-84E0-B3DCF6076822 Q35887797-E558AEE1-B139-4D61-A5C9-CA0FB9A595EE Q37027882-1E6429B7-6A1D-4056-878E-56C2195CD159 Q37108610-BF681159-FC04-4C6E-A77E-B0E3BC45F255 Q37128800-42CF9F6D-56E3-4E41-B156-0FBA548A8A62 Q37262387-EC3BE1A4-728F-436D-AA04-2FD9BA1395C5 Q37404944-E7476FDF-7A11-4B19-BF32-272897229EB7 Q37919897-955278B8-EC6E-4701-A455-C59077395AA7 Q38132267-7E31A071-00CE-4DC1-8D1B-D526E83F1696 Q38528489-8A9A5B95-BD99-43B8-83C2-E8E5DB591CF3 Q38976888-218E9757-868C-48C9-8F43-9CFD7BD96A66 Q39928699-A200B307-7B80-4D8B-A4EC-E5891783F7F1 Q41650697-E682088A-6163-4F5C-8D08-6222A55D9998 Q42247692-68C08A58-6C12-47A0-B43A-545F2F4D74A7 Q42279515-6DE6282F-BBF7-4B71-92D7-BF9C9A3D5D9E Q43773974-635E6B92-5CB9-47B0-8CBA-133D80BBFEBC Q43926397-A05AF356-5176-44C9-9342-61124B79BAE0 Q45028086-581A1DC5-FF98-4796-A86B-0A200C390F02 Q47570228-212D205E-9217-466A-9B78-5735F78470CA Q47636789-4D6D8535-98A3-45B9-B7D4-3C95D36CDC7E Q54442984-9264293D-A38C-4D6C-B88F-9A6DF16651AE

P2860

Towards elimination: measles susceptibility in Australia and 17 European countries.

http://www.wikidata.org/entity/Q37108714

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on March 2008

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Towards elimination: measles susceptibility in Australia and 17 European countries.

@en

Towards elimination: measles susceptibility in Australia and 17 European countries.

@nl

type

label

Towards elimination: measles susceptibility in Australia and 17 European countries.

@en

Towards elimination: measles susceptibility in Australia and 17 European countries.

@nl

prefLabel

Towards elimination: measles susceptibility in Australia and 17 European countries.

@en

Towards elimination: measles susceptibility in Australia and 17 European countries.

@nl

P1433

Q37108714-DDF9393A-E683-4A06-A6F0-AE0E2EEC9AF7

P1476

Q37108714-DAE0B956-7DA4-4A6D-BB10-9BF63DC68D7C

P2093

Q37108714-0551F887-339D-48B7-9C1E-DF79625F5456

Q37108714-1CD5A1C3-A855-43A8-AA55-3EE1DFD0FE04

Q37108714-256716C9-3E05-4CC4-A199-1E7A2EF71971

Q37108714-31E0DD8E-B292-492E-96F0-BFB292728EA7

Q37108714-3EE25668-1009-4690-9171-58D0854193BE

Q37108714-4E8DC909-ECF0-43B0-B63C-E5148FF83DA1

Q37108714-682F47A7-32D3-4224-A02B-E1E480997079

Q37108714-685D9399-1D4A-4675-B842-FFB4B03CE3AD

Q37108714-73A3059D-7B46-4DA6-B11D-CBF5C3BC0E52

Q37108714-755E175C-7715-46A2-8BF2-922A7CB7E668

P2860

Q37108714-11B26934-4C17-4425-95AD-8D345B1ED69C

Q37108714-1DC0AC9F-A73A-4422-B30A-39B46B269DA7

Q37108714-26AA5653-72D9-442C-9D92-3E3D1C858F8C

Q37108714-2E8D0876-8FB7-4075-A113-2C0E385BD571

Q37108714-3954507C-756A-4EA6-AF7E-1FF7720B195D

Q37108714-524FD71A-F616-4C97-8349-33F19A4B21F6

Q37108714-600908B2-9CFE-4495-9C76-C5B8F941215E

Q37108714-622F22CC-0C0B-48C0-86E8-AECE43B2BEEE

Q37108714-672C6201-E459-453E-AE8F-E66E688100EC

Q37108714-74A813D1-9F82-4476-9582-C03ECC7FCFE9

P304

Q37108714-12676785-04D7-494C-9867-2D97D30F27D7

P31

Q37108714-7EC0FCC0-05B9-468A-A4D3-1BD0C9F6D0A6

P356

Q37108714-CF73BEFF-842E-4B96-895A-B73AAC49356A

P407

Q37108714-CDC3BDF4-CBDD-42A6-BD2C-67B4554A7975

P433

Q37108714-236E6D8C-327C-4660-A3CB-E31BE22BB7DD

P478

Q37108714-558B1C92-63FD-4D9B-B2C6-5BA2A1034E48

P50

Q37108714-49E83982-0AB9-4ED7-BB40-7AB8095BF711

Q37108714-8A40D19A-2DDA-49D2-B98B-3D4A25C46D08

Q37108714-DEB9FE69-67C4-47F1-B7BA-8345EA391B1D

P577

Q37108714-B47833AE-FC64-45C2-87D3-0BFAD3537640

P5875

Q37108714-513B9E58-C461-4B23-BB54-52AA57D3E7D9

P698

Q37108714-939AA001-9C25-464B-BF53-E0F16383B578

P921

Q37108714-15F7907F-B63F-4DA4-B24F-1807F8707F9C

Q37108714-879514A8-6EE3-49FC-82FF-9CFA429DC3B0

P932

Q37108714-032078F3-2998-418E-B955-FAA1ADDD7286

P356

P1433

Bulletin of the World Health Organization

P1476

Towards elimination: measles susceptibility in Australia and 17 European countries.

@en

P2093

Adriana Pistol

http://www.w3.org/2001/XMLSchema#string

Algirdas Griskevicius

http://www.w3.org/2001/XMLSchema#string

Annedore Tischer

http://www.w3.org/2001/XMLSchema#string

Annette Siedler

http://www.w3.org/2001/XMLSchema#string

Arnis Duks

http://www.w3.org/2001/XMLSchema#string

Christopher Barbara

http://www.w3.org/2001/XMLSchema#string

Dani Cohen

http://www.w3.org/2001/XMLSchema#string

Heidi Theeten

http://www.w3.org/2001/XMLSchema#string

Jo Backhouse

http://www.w3.org/2001/XMLSchema#string

Kalman Bartha

http://www.w3.org/2001/XMLSchema#string

P2860

Standardization of measles, mumps and rubella assays to enable comparisons of seroprevalence data across 21 European countries and Australia.

The theory of measles elimination: implications for the design of elimination strategies.

Comparison of rubella seroepidemiology in 17 countries: progress towards international disease control targets.

The elimination of indigenous measles transmission in England and Wales.

Investigation of a rubella outbreak in Kyrgyzstan in 2001: implications for an integrated approach to measles elimination and prevention of congenital rubella syndrome.

The European Sero-Epidemiology Network.

Vaccine-induced measles virus antibodies after two doses of combined measles, mumps and rubella vaccine: a 12-year follow-up in two cohorts.

Persistence of vaccine-induced antibody to measles 26-33 years after vaccination.

Progress toward measles elimination in Romania after a mass vaccination campaign and implementation of enhanced measles surveillance.

Immunogenicity of second dose measles-mumps-rubella (MMR) vaccine and implications for serosurveillance.

P304

197-204

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2471/BLT.07.041129

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

86

http://www.w3.org/2001/XMLSchema#string

P50

Fernando de Ory

P577

2008-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

229003319

http://www.w3.org/2001/XMLSchema#string

P698

18368206

http://www.w3.org/2001/XMLSchema#string

P921

P932

2647410

http://www.w3.org/2001/XMLSchema#string